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The inhibitory effects of various nitrogen-containing sugars on porcine kidney trehalase were studied. Validamycin A, validoxylamine A and MDL 
25637 were found to be potent, time-dependent inhibitors of the enzyme in vitro. The validoxylamine A-inhibited enzyme showed slow but reversible 
reactivation over time (ri,r = 1.2 h). To our knowledge, this is the first report of time-dependent inhibition exhibited by either these particular amino- 
sugars or a trehalase. 
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1. INTRODUCTION 2.2. Methods 
Trehalase (a,~!-trehalose glucohydrolase, EC 
3.2.1.28) is the enzyme involved in the catabolism of 
the nonreducing disaccharide a,a-trehalose into 
glucose. Trehalose is a key storage carbohydrate in cer- 
tain insects, fungi and bacteria 111. The enzyme is 
widespread in nature, even in organisms presently 
known not store the sugar, such as mammals. There is 
currently great interest in the development of inhibitors 
of glycohydrolytic enzymes as biological probes of en- 
zyme mechanism and physiology as well as potential 
medicinal agents [2-51. Several compounds have 
recently been reported to inhibit trehalases from 
various sources [6-81. The current investigation con- 
cerns the previously unreported time-dependent inhibi- 
tion of porcine kidney trehalase by these N-containing 
compounds which are structural analogues of the 
natural substrate, trehalose (fig. 1). 
Trehalase activity was assayed at 30°C in a total vol. of 1 .O ml con- 
taining 10.0 mM trehalose, porcine kidney trehalase (2 mu) and 50 
mM Mes buffer (pH 5.6). After 30 min of incubation, the reaction 
was interrupted by the addition of 2.0 ml glucose oxidase-peroxidase 
(GOP) reagent [lo] which was used for the determination of the 
liberated glucose. After further incubation at 30°C for 30 min, 4.0 ml 
of 5 N HCl was added, and measurement at 525 nm was performed, 
I& values are concentrations of inhibitor necessary to inhibit 
trehalase by 50% at a trehalase concentration of 10.0 mM (KM = 3.7 
mM at pH 5.6). Determination of Ki values was estimated by Dixon 
plots of reciprocal activity vs inhibitor concentration. In preincuba- 
tion experiments, inhibitor and trehalase were incubated with shaking 
for the time stated, and the reaction was started by addition of 
trehalose. Otherwise, addition of the enzyme indicates the start of the 
reaction. Enzyme activity was proportional to protein concentration 
and time of incubation. For kinetic analysis, the ratio of inhibitor to 
enzyme concentration was never lower than 4O:l. None of the in- 
hibitors at the highest concentration used interfered with the assay of 
glucose by the GOP reagent. One unit of enzyme activity is defined 
as the quantity of enzyme which produces 1 .O rmol glucose/mm. All 
experiments were conducted in replicate. 
2. MATERIALS AND METHODS 
2.1. Materials 
For reaction progress curves, reactions with or without preincuba- 
tion with an inhibitor were started by the addition of 210 $ of 100 
pmol/ml trehalose in a final vol. of 2.21 ml in 50 mM Mes, pH 5.6. 
At various times, aliquots (300 ~1) were analyzed by GOP reagent (1 .O 
ml). The reaction was allowed to proceed for 30 min as described 
above before 2.0 ml of 5 N HCl was added. 
Porcine kidney trehalase (3.4 units/mg), glucose oxidase (type II), 
horseradish peroxidase (type II), trehalose dihydrate, o-dianisidine 
dihydrochloride, castanospermine and 2[N-morpholinolethane- 
sulfonic acid (Mes) were purchased from Sigma Chemical (St. Louis, 
MO). Validamycin A and MDL 25 637 were kind gifts from Takeda 
Chemical Industries (Tokyo, Japan) and Merrell Dow Research In- 
stitute (Ohio, USA), respectively. Validoxylamine A was obtained 
from the hydrolysis of validamycin A using a modified procedure of 
Kameda and colleagues [9] employing Dowex 5OW-X2 as catalyst. All 
other chemicals were from local suppliers and were of analytical 
grade. 
3. RESULTS AND DISCUSSION 
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The incorporation of appropriately positioned amino 
functionalities into sugar analogues has led to the pro- 
duction of potent inhibitors of glycohydrolytic enzymes 
[3,6-9,11-131. In some cases these effects are perhaps 
due to their purported resemblance, when protonated 
by essential glutamate or aspartate functionalities in the 
enzymes, to transition state or reactive intermediate 
structures. To further understand the connection be- 
tween inhibitor structure and enzyme inhibition, pig 
kidney trehalase was investigated with various struc- 
tural analogues of its natural substrate, trehalose. Pig 
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Fig.1. Structures of trehalose and selected N-containing compounds that are inhibitors of trehalase. 
kidney trehalase has not previously been studied with 
inhibitors of this type. In this investigation a time- 
dependent inhibition by 3 trehalose analogues, MDL 
25 637, validamycin A and validoxylamine A has been 
observed. In addition, this is the first report of time- 
dependent inhibition exhibited by a trehalase or these 
compounds. 
Castanospermine, an aminocyclitol having ~hibitory 
activity against several glycohydrolases [ 14,151, has 
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Fig.2. Linew~ver-Burk plot of enzyme activity in the presence of 
v~idoxylamine A. 
good inhibitory activity against the trehalase (IGO = 
5.5 x 10e6 M). The analogues that are structur~ly 
similar to the natural substrate were more potent hav- 
ing IGO values of 4.5 x 10v9 M, 1.1 x 10T8 M, and 
1 .O x lo- ’ M for validoxylamine A, MDL 25 637 and 
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Fig.3. Inhibition of porcine kidney trehalase by vahdoxylamine A. 
Enzyme and inhibitor were preincubated for 0 (0), 30 (0). 60 (A) 
and 120 (‘I) min at room temperature before the addition of IO0 ~1 
of 100 @al/ml trehalose in a final vol. of 1.0 ml. Values are 
presented as a percent of the enzyme activity. Activity was 4-7 nmoi 
glucosefmin. 
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Fig.4. Reaction progress curve. Porcine kidney trehalase was in- 
cubated with different concentrations of vaiidoxylamine A. 
validamycin A, respectively. Without preincubation, 
validoxylamine A is a competitive inhibitor of pig 
trehalase (fig.2) with a Ki value of 2x low9 M. MDL 
25637 and validamycin A are also competitive in- 
hibitors of the enzyme @IO& not shown) with & values 
of 3 x foe9 M and 6x lo-* M, respectively. 
However, in preincubation experiments, validox- 
ylamine A showed noncompetitive inhibition upon sim- 
ple steady-state kinetic analysis (data not shown). Fig.3 
illustrates the relationship of preincubation time to en- 
zyme activity for v~jdo~~am~ne A. These observa- 
tions, also observed for MDL 25637 and v~idamycin 
A suggest hat the interaction of these inhibitors and 
the enzyme is a slow binding process [16,17], Analysis 
of the product vs time plot for the trehalose inhibitor 
anaiogues by the method of Baici and Gyger-Marazzi 
[is] resuhed in presteady state I& vahzes for vahdox- 
ylamine A (fig.4). MDL 25637 and validamycin A of 
8.5 x lo-r0 M, 2.2 x 10e9 M and 2.3 x 10-s M, respec- 
tively. The /con values for validoxylamine A, MDL 
25637 and validamycin A were calculated to be 
2.7x ld M-~s-~, 1.8~10~ M-%-l and 1.4~104 
M- rs - ‘) respectivefy. The &,ff values obtained by the 
above approach for vdidoxylamine A, MDL 25637 
and validamycin A were 2.3 x 10e4 s-r (f1/2 = 1.2 h), 
3.8 x 10m4 s- ’ and 3.3 x ION4 s- ‘, respectively. Plots 
of reaction progress with and without preincubation 
with valido~ylam~e A indicate linear first order 
kinetics upon prein~ubation (fig.5). 
Investigations to determine the reversibility and the 
expected reactivation of the inhibited enzyme upon 
dilution were performed. Exhaustive dialysis of the en- 
zyme preincubated with validoxylamine A resulted in 
time-dependent reactivation of the enzyme activity 
(f”rg.5). Interestingly, a recent report has shown that 
time-dependent inhibition of cu-ghrcosidase with 
castanospermine is a nonreversible process even upon 
extensive dialysis [ 181. This phenomenon is not observ- 
19.Shr 
Fi8.5. Reaction progress curve. No inhibitor (0), 12.5 nM vrdidox- 
ylamine A without preincubation {A), and 12.5 nM validoxylamine 
A preincubated for 60 min at room temperature [A). Preincubated 
samples (2.0 mT) were dialyzed against 500 ml of 25 mM Mes buffer, 
pH 5.6. At appropriate times, the content of the diafysis bags was 
transferred into test tubes and reactions were started by the addition 
of 210 pl of 100 pmol/ml trehalose (dashed lines). 
ed with porcine kidney trehafase in the present studies. 
The interaction of MDL 25637, validamycin A and 
validoxylamine A with porcine kidney trehafase ap- 
pears to be in the category of slow-binding inhibition. 
Apparently, in the appropriate molecular context, an 
amino functionality can be positioned either in the ring 
structure or in the glycosidic bond to produce potent 
tim~depende~t interactions with the same enzyme. 
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